pulmonary involvement Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Unknown (2)

Observational (2)

Assistance Publique - Hôpitaux de Paris (1)
Federal University of Rio Grande do Sul (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadfever

I am/have/hadraynaud's phenomenon

I am/have/hadfraction of inspired oxygen (fio2)

I am/have/hadcovid-19

I am/have/hadrespiratory symptom

I am/have/hadFIO2

I am/have/hadpulmonary involvement

I am/have/hadchest imaging

I am/have/hadacute respiratory distress

I am/have/hadacute respiratory syndrome (sars)

I am/have/hadrespiratory tract infection

I am/have/hadscleroderma

I am/have/hadanxiety

I am/have/hadchest ct

I am/have/hadraynaud's syndrome

I am/have/hadprogressive systemic sclerosis

I am/have/hadcoronavirus infection

I am/have/hadraynaud disease

I am/have/hadchest x-ray

I am/have/hadpulmonary function tests

added new label for I am/have/had

more

I am looking for

I am looking forcorticosteroids

I am looking forcyclophosphamide

I am looking forimmunosuppressive agents

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Dermatology
Recruiting

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

To define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.

raynaud's syndrome

raynaud's phenomenon

progressive systemic sclerosis

raynaud disease

chest x-ray

0 views
19 Feb, 2024

For pediatric ages
For Seniors
Recruiting in 100s
Observational Study
all
Recruiting

Lung Function Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus (SARS-CoV-2) that can progress to severe disease requiring hospitalization and oxygen support in around14% of the cases and 5% require admission in intensive care unit. The medium and long-term impact in survivors of severe COVID-19 …

fever

fraction of inspired oxygen (fio2)

covid-19

respiratory symptom

FIO2

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.